Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1995
06/14/1995EP0656773A1 Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions.
06/14/1995EP0656771A1 Printed transdermal drug delivery device
06/14/1995EP0569457B1 Use of thiazolo-[2,3-a]isoindole derivatives as antiviral medicaments and novel thiazolo- [2,3-a]isoindole derivatives
06/14/1995EP0525111B1 Antiinflammatory hydroxamic acids and n-hydroxyureas
06/14/1995EP0442982B1 Topical compositions containing lycd and other topically active medicinal ingredients
06/14/1995DE4342232A1 Solid prostaglandin E1 formulations
06/14/1995CN1103581A Induced labor injection and its preparing method
06/14/1995CN1103580A New use
06/14/1995CN1103578A Hair restorer and its preparation
06/14/1995CN1028879C Method for making anti-cancer vitamin vinegar
06/14/1995CN1028866C Method for preparation of methylene bis-phosphonic acid derivatives
06/14/1995CN1028864C Macrolide compounds, their preparation and their use
06/14/1995CN1028863C 3-cycloalkyl-prop-2-enamide derivatives
06/14/1995CA2136118A1 Pharmaceutical composition for controlled release
06/14/1995CA2135861A1 Oxazolidin-2-one derivatives
06/14/1995CA2111320A1 Pharmaceutical granulate
06/13/1995US5424471 Crystalline amifostine compositions and methods of the preparation and use of same
06/13/1995US5424464 p-[Bis(2-chloroethyl)amino]phenylalanine compounds
06/13/1995US5424463 Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process
06/13/1995US5424456 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof
06/13/1995US5424451 Process for preparing aminoalkylcarbamic esters of eseroline
06/13/1995US5424450 Angiotensin II receptor blocking imidazolinone derivatives
06/13/1995US5424448 Preparation of carbonic anhydrase inhibitors
06/13/1995US5424447 Inhibitors of nitric oxide formation from arginine
06/13/1995US5424441 Nootropic, antiepileptic agents
06/13/1995US5424435 1-hydroxy-6-substituted-2-pyridones
06/13/1995US5424434 Production on 3-oxadiazolyl-1,6-naphthyridine derivatives
06/13/1995US5424433 Benzodiazepine receptor agonist
06/13/1995US5424428 (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]pr
06/13/1995US5424426 Dithiolanylglycine-containing HIV protease inhibitors of the hydroxyethylene isostere type
06/13/1995US5424425 Analgesics, antidepressants, hypotensive agent and treats irritable bowel syndrome and congestive heart failure
06/13/1995US5424416 Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides
06/13/1995US5424406 Dihydrochalcone derivatives which are hypoglycemic agents
06/13/1995US5424400 Senescent cell derived inhibitors of DNA synthesis
06/13/1995US5424333 Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines
06/13/1995US5424332 For treating psoriasis and psoriatic arthritis; using fumaric acid monoalkylester calcium, iron or magnesium salt
06/13/1995US5424331 Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis
06/13/1995US5424329 Indole-2-carboxamides as inhibitors of cell adhesion
06/13/1995US5424328 Treatment of central nervous system disorders
06/13/1995US5424326 Treats cardiovascular disorder angina pectoris and erectile dysfunctions
06/13/1995US5424319 Renin inhibitors
06/13/1995US5424318 Treating dementia, cerebrovascular diseases
06/13/1995US5424315 Treating herpes viral infections, particularly cytomegalovirus
06/13/1995US5424314 Anti-anoxic
06/13/1995US5424313 Bibyclic heteroacrylpiperazine derivatives having psychotropic activity, and pharmaceutical compositions containing these derivatives
06/13/1995US5424312 Treating central nervous system disorders, high blood pressure
06/13/1995US5424311 A viricides for treating viral diseases; HIV enzyme inhibitor
06/13/1995US5424310 Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component
06/13/1995US5424309 Hypotensive agents
06/13/1995US5424308 Immunomodulating agents
06/13/1995US5424307 Renin inhibitors
06/13/1995US5424306 Crystalline carbapenem derivative
06/13/1995US5424305 Treating a cancer bladder by photosensitive a porphyrins or a chlorophylls antitumor agent
06/13/1995US5424303 For treating hypercholesterolemia and hyperlipidemia
06/13/1995US5424302 Process for the production of starch degradation products with a narrow molecular weight distribution
06/13/1995US5424301 Cognition activators
06/13/1995US5424300 Method for treatment of chronic fatigue syndrome
06/13/1995US5424298 Topical powder compositions containing a cyclic AMP derivative
06/13/1995US5424297 Hypotensive agents
06/13/1995US5424296 2-Halo-2'-deoxyadenosines as therapeutic agents against malignant astrocytoma
06/13/1995US5424295 9-β-D-arabinofuranasyl-2-amino-6-methaoxy-9H-purine
06/13/1995US5424294 Modified gangliosides and the functional derivatives thereof
06/13/1995US5424293 Phenylimidazolidine derivatives and their use
06/13/1995US5424292 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases
06/13/1995US5424201 Method for preparing an antitumor dextran using Lactobacillus confusus
06/13/1995US5424187 Detection of chlamydial markers for diagnosis of infections in coronary arteries
06/13/1995US5424075 Delivery system for enhanced onset and increased potency
06/13/1995US5424073 Anticancer agents
06/13/1995US5424069 Production of crystalline penem
06/13/1995US5424064 Treatment of reflux esophagitis using dimethylpolysiloxane
06/13/1995US5424063 Aids therapy
06/13/1995US5424057 Medical diagnosis
06/13/1995US5424055 Ultraviolet screening composited oxide and process for producing the same
06/13/1995CA1335897C (e)-2-(p-fluorophenethyl)-3-fluoroallylamine
06/13/1995CA1335892C Saccharide derivatives
06/11/1995CA2137524A1 Aryl-substituted alkoxycarbonyl-1,4-dihydropyridine-5- carboxylic acid esters
06/11/1995CA2137519A1 4-phenyl-3-substituted 1,4-dihydropyridine esters
06/11/1995CA2137518A1 Dihydropyridines with substituted esters
06/10/1995CA2137613A1 Process for the preparation of epibatidine
06/10/1995CA2137611A1 Epi-epibatidine derivatives
06/10/1995CA2137605A1 Combination preparations comprising a quinoxaline and a nucleoside
06/09/1995CA2137446A1 3-(phenylalkylaminoalkyloxy)-5-phenylpyrazole compounds, intermediates for their preparation and pharmaceutical compositions containing them
06/08/1995WO1995015595A1 High-density interconnect technique
06/08/1995WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995WO1995015381A2 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
06/08/1995WO1995015378A1 Antisense oligonucleotides having tumorigenicity-inhibiting activity
06/08/1995WO1995015373A2 Inhibition of dna methyltransferase
06/08/1995WO1995015343A1 POLY-β-1→4-N-ACETYLGLUCOSAMINE
06/08/1995WO1995015333A1 Nucleosides and oligonucleotides containing boron clusters
06/08/1995WO1995015327A1 N-substituted azabicycloalkane derivatives as neuroleptika asf
06/08/1995WO1995015326A1 Novel indole or salt thereof
06/08/1995WO1995015324A1 Substituted aminoalkylaminopyridines
06/08/1995WO1995015318A1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
06/08/1995WO1995015317A1 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders
06/08/1995WO1995015316A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/08/1995WO1995015315A1 1,5-diphenyl pyrazole compounds for treatment of inflammation
06/08/1995WO1995015312A1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics
06/08/1995WO1995015311A1 Tachykinin antagonists
06/08/1995WO1995015310A1 Prolyl endopeptidase inhibitors
06/08/1995WO1995015309A1 Dp-iv-serine protease inhibitors
1 ... 7011 7012 7013 7014 7015 7016 7017 7018 7019 7020 7021 7022 7023 7024 7025 7026 7027 7028 7029 7030 7031 ... 7860